SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ocugen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 17, 2021

New York, New York – (Newsfile Corp. – August 15, 2021) – The following statement is issued by Levi & Korsinsky, LLP:

To: Any person or entity who purchased or otherwise acquired securities of Ocugen, Inc. (“Ocugen”) (NASDAQ: OCGN) between February 2, 2021 and June 10, 2021. You are hereby notified that a securities class action has been filed in the United States District Court for the Eastern District of Pennsylvania. For more information go to:

Ocugen, Inc. Loss Submission Form

or contact Joseph E. Levi, Esq. either by email at jlevi@levikorsinsky.com or by phone at (212) 363-7500. There are no costs or obligations for you.

Ocugen, Inc. NEWS – OCGN NEWS

CASE DETAILS: According to the complaint filed: (i) the information submitted to the US Food and Drug Administration (“FDA”) was insufficient to support an Emergency Authorization (“EUA”); (ii) Ocugen would not file an EUA with the FDA, (iii) as a result of the foregoing, the Company’s financial statements and Defendants’ statements about Ocugen’s business, operations and prospects were false, misleading and / or unfounded.

WHAT THIS MEANS FOR SHAREHOLDERS: If you have suffered damage in Ocugen, you can apply until August 17, 2021 for the court to appoint you as the main plaintiff. Your ability to partake in a recovery does not require you to act as the lead plaintiff.

NO CHARGE TO YOU: If you purchased Ocugen securities between February 2, 2021 and June 10, 2021, you may be entitled to compensation with no out-of-pocket expenses or fees.

PROTECT YOUR FINANCIAL INTERESTS: Fill out this short submission form https://www.zlk.com/pslra-1/ocugen-inc-information-request-form?prid=18567&wire=5 or call 212-363-7500 to discuss the case with Joseph E. Levi, Esq.

WHY LEVI & KORSINSKY: Levi & Korsinsky have a proven record of winning hundreds of millions of dollars worth of cases for shareholders over a period of 20 years. We represent and fight for shareholders who have been disadvantaged by companies.

The story goes on

Levi & Korsinsky is a nationally recognized law firm with offices in New York, California, Connecticut and Washington, DC. The firm’s founding partners, Joseph Levi and Eduard Korsinsky, have represented shareholders and institutional clients for nearly 20 years and have had remarkable results for clients in the US and internationally. The company, with more than 80 employees, is committed to promoting, maintaining and maintaining a culture of diversity, equality and inclusion for employees and those we represent. Our attorneys have extensive experience representing investors in securities disputes with a track record of recovering hundreds of millions of dollars in cases. Levi & Korsinsky was ranked one of the leading securities litigation firms in the United States in the SCAS Top 50 Report by Institutional Shareholder Services (“ISS”) for 7 consecutive years. The SCAS Top 50 Report identifies the leading securities law firms in the country, and year on year ISS has recognized Levi & Korsinsky as the leading law firm in securities class action.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 10th floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/93204